TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-121273 | Pharmaceutics
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Transdermal Therapeutic Systems (TTS) Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET
7.1 GLOBAL TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA TRANSDERMAL THERAPEUTIC SYSTEMS (TTS) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Hisamitsu
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Lohmann
16.3 Novartis
16.4 Mylan
16.5 Johnson & Johnson
16.6 GSK
16.7 Pfizer
16.8 Nitto Denko
16.9 Teve (Actavis)
16.10 Teikoku Seiyaku
16.11 Dr Reddy's Laboratories
16.12 Mundipharma
16.13 Bayer
16.14 Haw Par
16.15 Qizheng
16.16 UCB Pharma
16.17 Lingrui
16.18 Huarun 999
16.19 Endo
16.20 Sanofi
16.21 Nichiban
16.22 Luye Pharma Group
16.23 Beijing Tide Pharmaceutical
16.24 Mentholatum Company
16.25 Laboratoires Genevrier
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Market by Type :Methyl Salicylate
Nitroglycerin
Fentanyl
Nicotine
Rivastigmine
Estradiol
Others
Market by Application :
OTC Channel
Retail Channel
E-Commerce Channel
Companies
Hisamitsu
Lohmann
Novartis
Mylan
Johnson & Johnson
GSK
Pfizer
Nitto Denko
Teve (Actavis)
Teikoku Seiyaku
Dr Reddy's Laboratories
Mundipharma
Bayer
Haw Par
Qizheng
UCB Pharma
Lingrui
Huarun 999
Endo
Sanofi
Nichiban
Luye Pharma Group
Beijing Tide Pharmaceutical
Mentholatum Company
Laboratoires Genevrier
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.